 | • レポートコード：GIR201112991 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ラタノプロストの世界市場を調査対象にし、ラタノプロストの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ブランド薬、ジェネリック薬）、用途別分析（開放隅角緑内障、閉鎖隅角緑内障）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer、Apotex、Mylan、CR Zizhu、Novartis、Taj Pharma、Teva ・メーカー別販売量、売上、市場シェア ・ラタノプロストの地域別市場分析 ・ラタノプロストの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ラタノプロストのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ラタノプロストのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ラタノプロストの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ラタノプロストの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ラタノプロストの種類別市場規模2015-2020：ブランド薬、ジェネリック薬 ・ラタノプロストの用途別市場規模2015-2020：開放隅角緑内障、閉鎖隅角緑内障 ・ラタノプロストの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Latanoprost market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Latanoprost market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 1468.8 million by 2025, from USD 1351.4 million in 2019.
Market segmentation
Latanoprost market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Latanoprost market has been segmented into
Brand Drug
Generic Drug
By Application, Latanoprost has been segmented into:
Open-angle Glaucoma
Close-angle Glaucoma
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Latanoprost market presented in the report. This section sheds light on the sales growth of different regional and country-level Latanoprost markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Latanoprost market.
The report offers in-depth assessment of the growth and other aspects of the Latanoprost market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Latanoprost Market Share Analysis
Latanoprost competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Latanoprost sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Latanoprost sales, revenue and market share for each player covered in this report.
The major players covered in Latanoprost are:
Pfizer
Apotex
Mylan
CR Zizhu
Novartis
Taj Pharma
Teva
Among other players domestic and global, Latanoprost market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Latanoprost product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Latanoprost, with price, sales, revenue and global market share of Latanoprost in 2018 and 2019.
Chapter 3, the Latanoprost competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Latanoprost breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Latanoprost market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Latanoprost sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Latanoprost Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Latanoprost Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Latanoprost Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Open-angle Glaucoma
1.3.3 Close-angle Glaucoma
1.4 Overview of Global Latanoprost Market
1.4.1 Global Latanoprost Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Apotex
2.2.1 Apotex Details
2.2.2 Apotex Major Business
2.2.3 Apotex SWOT Analysis
2.2.4 Apotex Product and Services
2.2.5 Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan SWOT Analysis
2.3.4 Mylan Product and Services
2.3.5 Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CR Zizhu
2.4.1 CR Zizhu Details
2.4.2 CR Zizhu Major Business
2.4.3 CR Zizhu SWOT Analysis
2.4.4 CR Zizhu Product and Services
2.4.5 CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Taj Pharma
2.6.1 Taj Pharma Details
2.6.2 Taj Pharma Major Business
2.6.3 Taj Pharma Product and Services
2.6.4 Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Product and Services
2.7.4 Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Latanoprost Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Latanoprost Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Latanoprost Manufacturer Market Share in 2019
3.3.2 Top 6 Latanoprost Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Latanoprost Sales, Revenue and Market Share by Regions
4.1.1 Global Latanoprost Sales and Market Share by Regions (2015-2020)
4.1.2 Global Latanoprost Revenue and Market Share by Regions (2015-2020)
4.2 North America Latanoprost Sales and Growth Rate (2015-2020)
4.3 Europe Latanoprost Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Latanoprost Sales and Growth Rate (2015-2020)
4.5 South America Latanoprost Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Latanoprost Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Latanoprost Sales, Revenue and Market Share by Country
5.1.1 North America Latanoprost Sales and Market Share by Country (2015-2020)
5.1.2 North America Latanoprost Revenue and Market Share by Country (2015-2020)
5.2 United States Latanoprost Sales and Growth Rate (2015-2020)
5.3 Canada Latanoprost Sales and Growth Rate (2015-2020)
5.4 Mexico Latanoprost Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Latanoprost Sales, Revenue and Market Share by Country
6.1.1 Europe Latanoprost Sales and Market Share by Country (2015-2020)
6.1.2 Europe Latanoprost Revenue and Market Share by Country (2015-2020)
6.2 Germany Latanoprost Sales and Growth Rate (2015-2020)
6.3 UK Latanoprost Sales and Growth Rate (2015-2020)
6.4 France Latanoprost Sales and Growth Rate (2015-2020)
6.5 Russia Latanoprost Sales and Growth Rate (2015-2020)
6.6 Italy Latanoprost Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Latanoprost Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Latanoprost Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Latanoprost Revenue and Market Share by Regions (2015-2020)
7.2 China Latanoprost Sales and Growth Rate (2015-2020)
7.3 Japan Latanoprost Sales and Growth Rate (2015-2020)
7.4 Korea Latanoprost Sales and Growth Rate (2015-2020)
7.5 India Latanoprost Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Latanoprost Sales and Growth Rate (2015-2020)
7.7 Australia Latanoprost Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Latanoprost Sales, Revenue and Market Share by Country
8.1.1 South America Latanoprost Sales and Market Share by Country (2015-2020)
8.1.2 South America Latanoprost Revenue and Market Share by Country (2015-2020)
8.2 Brazil Latanoprost Sales and Growth Rate (2015-2020)
8.3 Argentina Latanoprost Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Latanoprost Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Latanoprost Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Latanoprost Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Latanoprost Sales and Growth Rate (2015-2020)
9.3 Turkey Latanoprost Sales and Growth Rate (2015-2020)
9.4 Egypt Latanoprost Sales and Growth Rate (2015-2020)
9.5 South Africa Latanoprost Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Latanoprost Sales and Market Share by Type (2015-2020)
10.2 Global Latanoprost Revenue and Market Share by Type (2015-2020)
10.3 Global Latanoprost Price by Type (2015-2020)
11 Global Latanoprost Market Segment by Application
11.1 Global Latanoprost Sales Market Share by Application (2015-2020)
11.2 Global Latanoprost Revenue Market Share by Application (2015-2020)
11.3 Global Latanoprost Price by Application (2015-2020)
12 Market Forecast
12.1 Global Latanoprost Sales, Revenue and Growth Rate (2021-2025)
12.2 Latanoprost Market Forecast by Regions (2021-2025)
12.2.1 North America Latanoprost Market Forecast (2021-2025)
12.2.2 Europe Latanoprost Market Forecast (2021-2025)
12.2.3 Asia-Pacific Latanoprost Market Forecast (2021-2025)
12.2.4 South America Latanoprost Market Forecast (2021-2025)
12.2.5 Middle East & Africa Latanoprost Market Forecast (2021-2025)
12.3 Latanoprost Market Forecast by Type (2021-2025)
12.3.1 Global Latanoprost Sales Forecast by Type (2021-2025)
12.3.2 Global Latanoprost Market Share Forecast by Type (2021-2025)
12.4 Latanoprost Market Forecast by Application (2021-2025)
12.4.1 Global Latanoprost Sales Forecast by Application (2021-2025)
12.4.2 Global Latanoprost Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Latanoprost Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Latanoprost by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Latanoprost Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Latanoprost Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Latanoprost Major Business
Table 10. Pfizer Latanoprost Total Revenue (USD Million) (2018-2019)
Table 11. Pfizer SWOT Analysis
Table 12. Pfizer Latanoprost Product and Services
Table 13. Pfizer Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Apotex Basic Information, Manufacturing Base and Competitors
Table 15. Apotex Latanoprost Major Business
Table 16. Apotex Latanoprost Total Revenue (USD Million) (2018-2019)
Table 17. Apotex SWOT Analysis
Table 18. Apotex Latanoprost Product and Services
Table 19. Apotex Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Mylan Basic Information, Manufacturing Base and Competitors
Table 21. Mylan Latanoprost Major Business
Table 22. Mylan Latanoprost Total Revenue (USD Million) (2018-2019)
Table 23. Mylan SWOT Analysis
Table 24. Mylan Latanoprost Product and Services
Table 25. Mylan Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. CR Zizhu Basic Information, Manufacturing Base and Competitors
Table 27. CR Zizhu Latanoprost Major Business
Table 28. CR Zizhu Latanoprost Total Revenue (USD Million) (2018-2019)
Table 29. CR Zizhu SWOT Analysis
Table 30. CR Zizhu Latanoprost Product and Services
Table 31. CR Zizhu Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Novartis Basic Information, Manufacturing Base and Competitors
Table 33. Novartis Latanoprost Major Business
Table 34. Novartis Latanoprost Total Revenue (USD Million) (2018-2019)
Table 35. Novartis SWOT Analysis
Table 36. Novartis Latanoprost Product and Services
Table 37. Novartis Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Taj Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Taj Pharma Latanoprost Major Business
Table 40. Taj Pharma Latanoprost Total Revenue (USD Million) (2018-2019)
Table 41. Taj Pharma SWOT Analysis
Table 42. Taj Pharma Latanoprost Product and Services
Table 43. Taj Pharma Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Teva Basic Information, Manufacturing Base and Competitors
Table 45. Teva Latanoprost Major Business
Table 46. Teva Latanoprost Total Revenue (USD Million) (2018-2019)
Table 47. Teva SWOT Analysis
Table 48. Teva Latanoprost Product and Services
Table 49. Teva Latanoprost Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Latanoprost Sales by Manufacturer (2018-2019) (M Unit)
Table 51. Global Latanoprost Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Latanoprost Sales by Regions (2015-2020) (M Unit)
Table 53. Global Latanoprost Sales Market Share by Regions (2015-2020)
Table 54. Global Latanoprost Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Latanoprost Sales by Countries (2015-2020) (M Unit)
Table 56. North America Latanoprost Sales Market Share by Countries (2015-2020)
Table 57. North America Latanoprost Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Latanoprost Revenue Market Share by Countries (2015-2020)
Table 59. Europe Latanoprost Sales by Countries (2015-2020) (M Unit)
Table 60. Europe Latanoprost Sales Market Share by Countries (2015-2020)
Table 61. Europe Latanoprost Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Latanoprost Sales by Regions (2015-2020) (M Unit)
Table 63. Asia-Pacific Latanoprost Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Latanoprost Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Latanoprost Sales by Countries (2015-2020) (M Unit)
Table 66. South America Latanoprost Sales Market Share by Countries (2015-2020)
Table 67. South America Latanoprost Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Latanoprost Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Latanoprost Sales by Countries (2015-2020) (M Unit)
Table 70. Middle East & Africa Latanoprost Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Latanoprost Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Latanoprost Revenue Market Share by Countries (2015-2020)
Table 73. Global Latanoprost Sales by Type (2015-2020) (M Unit)
Table 74. Global Latanoprost Sales Share by Type (2015-2020)
Table 75. Global Latanoprost Revenue by Type (2015-2020) (USD Million)
Table 76. Global Latanoprost Revenue Share by Type (2015-2020)
Table 77. Global Latanoprost Sales by Application (2015-2020) (M Unit)
Table 78. Global Latanoprost Sales Share by Application (2015-2020)
Table 79. Global Latanoprost Sales Forecast by Regions (2021-2025) (M Unit)
Table 80. Global Latanoprost Market Share Forecast by Regions (2021-2025)
Table 81. Global Latanoprost Sales Forecast by Type (2021-2025) (M Unit)
Table 82. Global Latanoprost Market Share Forecast by Type (2021-2025)
Table 83. Global Latanoprost Sales Forecast by Application (2021-2025)
Table 84. Global Latanoprost Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Latanoprost Picture
Figure 2. Global Sales Market Share of Latanoprost by Type in 2019
Figure 3. Brand Drug Picture
Figure 4. Generic Drug Picture
Figure 5. Latanoprost Sales Market Share by Application in 2019
Figure 6. Open-angle Glaucoma Picture
Figure 7. Close-angle Glaucoma Picture
Figure 8. Global Latanoprost Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Latanoprost Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Latanoprost Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Latanoprost Sales Market Share by Manufacturer in 2019
Figure 29. Global Latanoprost Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Latanoprost Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Latanoprost Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 34. Global Latanoprost Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Latanoprost Revenue Market Share by Regions (2015-2020)
Figure 36. Global Latanoprost Revenue Market Share by Regions in 2018
Figure 37. North America Latanoprost Sales and Growth Rate (2015-2020)
Figure 38. Europe Latanoprost Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Latanoprost Sales and Growth Rate (2015-2020)
Figure 40. South America Latanoprost Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Latanoprost Sales and Growth Rate (2015-2020)
Figure 42. North America Latanoprost Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Latanoprost Sales Market Share by Countries (2015-2020)
Figure 44. North America Latanoprost Sales Market Share by Countries in 2018
Figure 45. North America Latanoprost Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Latanoprost Revenue Market Share by Countries in 2018
Figure 47. United States Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 48. Canada Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 49. Mexico Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 50. Europe Latanoprost Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Latanoprost Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Latanoprost Revenue Market Share by Countries in 2019
Figure 53. Germany Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 54. UK Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 55. France Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 56. Russia Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 57. Italy Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 58. Asia-Pacific Latanoprost Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Latanoprost Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Latanoprost Revenue Market Share by Regions 2019
Figure 61. China Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 62. Japan Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 63. Korea Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 64. India Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 65. Southeast Asia Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 66. South America Latanoprost Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Latanoprost Sales Market Share by Countries in 2019
Figure 68. South America Latanoprost Revenue Market Share by Countries in 2019
Figure 69. Brazil Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 70. Argentina Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 71. Middle East and Africa Latanoprost Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Latanoprost Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Latanoprost Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Latanoprost Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 76. Egypt Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 77. Turkey Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 78. South Africa Latanoprost Sales and Growth Rate (2015-2020) (M Unit)
Figure 79. Global Latanoprost Sales and Growth Rate (2021-2025) (M Unit)
Figure 80. Global Latanoprost Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Latanoprost Market Forecast (2021-2025) (M Unit)
Figure 82. Europe Sales Latanoprost Market Forecast (2021-2025) (M Unit)
Figure 83. Asia-Pacific Sales Latanoprost Market Forecast (2021-2025) (M Unit)
Figure 84. South America Sales Latanoprost Market Forecast (2021-2025) (M Unit)
Figure 85. Middle East & Africa Sales Latanoprost Market Forecast (2021-2025) (M Unit)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
緑内障レーザー治療の世界市場 2020年 Market Overview The global Glaucoma Laser Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Laser Thera…- 緑内障レーザー装置の世界市場 2020年 Market Overview The global Glaucoma Laser Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Laser Devices…
- 緑内障点眼薬の世界市場 2020年 Market Overview The global Glaucoma Eye Drops market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Eye Drops market …
- 緑内障手術療法の世界市場 2020年 Market Overview The global Glaucoma Surgery Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Surgery T…
- 動物用ジェネリック医薬品の世界市場 2020年 Market Overview The global Animal Generic Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Animal Generic Drug marke…